medical condition treated by tirzepatide FDA Says Compounded Must Exit the Market Zepbound (Tirzepatide) for Chronic Weight

Your body essentially learns to work with the medication over time

Wang YG, Yang TL

Branded Medications As you research your options, you will likely encounter both branded medications and compounded versions

10.3389/fnagi.2017.00195 127 EngenP

Chest pain, shortness of breath, or rapid heart rate : which could indicate cardiovascular complications Severe weakness or inability to perform normal activities : suggesting possible electrolyte imbalances or other serious conditions You should also schedule a non-urgent appointment if you notice unintentional excessive weight loss (more than 23 pounds per week consistently), difficulty maintaining adequate nutrition , or new symptoms such as cold intolerance, hair loss, or mood changes that might suggest thyroid dysfunction or other endocrine issues